CVS Health (CVS) valuation history
Above its usual range
As of
CVS's EV/EBITDA of 12.9x is higher than 78% of its available weekly readings from the last five years.
Share EV/EBITDA history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
EV/EBITDA at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | EV/EBITDA | 5-year rank |
|---|---|---|
| 16.0× | 99% | |
| 7.7× | 26% | |
| 8.0× | 15% | |
| 14.4× | 88% | |
| 10.1× | 70% | |
| 7.4× | 14% | |
| 11.3× | 65% | |
| 10.7× | 71% | |
| 8.2× | 11% | |
| 6.6× | 1% |
Loading related research…
About this history
- What is CVS's current EV/EBITDA?
- CVS's EV/EBITDA of 12.9x is higher than 78% of its available weekly readings from the last five years.
- What is CVS's five-year median EV/EBITDA?
- The median, or middle weekly reading, is 10.1× over the last five years. Available history contains 859 weekly observations from May 10, 2010 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.